Compare ELV & APO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELV | APO |
|---|---|---|
| Founded | 1944 | 1990 |
| Country | United States | United States |
| Employees | N/A | 4130 |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.4B | 71.9B |
| IPO Year | 2001 | N/A |
| Metric | ELV | APO |
|---|---|---|
| Price | $394.69 | $135.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 12 |
| Target Price | ★ $383.56 | $149.00 |
| AVG Volume (30 Days) | 1.7M | ★ 3.6M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.83% | 1.67% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.00 | N/A |
| Revenue | ★ $199,125,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.07 | $13.15 |
| P/E Ratio | $49.59 | ★ $22.63 |
| Revenue Growth | ★ 12.49 | N/A |
| 52 Week Low | $273.71 | $99.56 |
| 52 Week High | $412.96 | $157.28 |
| Indicator | ELV | APO |
|---|---|---|
| Relative Strength Index (RSI) | 76.52 | 68.07 |
| Support Level | $305.50 | $120.92 |
| Resistance Level | N/A | $137.51 |
| Average True Range (ATR) | 9.10 | 4.47 |
| MACD | 1.52 | 0.29 |
| Stochastic Oscillator | 85.63 | 94.99 |
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Apollo is one of the world's largest alternative asset managers, with $938.4 billion in total assets under management, or AUM, including $709.1 billion in fee-earning assets, at the end of 2025. The company has two core operating segments: asset management and retirement services. Apollo operates with scale in each of its major product lines—private equity (with $128.4 billion in total AUM and $75.0 billion in fee-earning AUM), real estate/real assets ($60.8 billion/$27.6 billion), and credit ($749.2 billion/$606.5 billion). Apollo has a distribution profile that is likely not too far off from the industry averages—with 84% of its assets held by institutional investors and 16% by high-net-worth clients.